Search

Search Constraints

You searched for: Issue Volume 12:Supplement 7S(2016)Part 5

Search Results

81. O2‐13‐02: Humanized Mab, Armanezumab Targeting N‐Terminus of Pathological Tau: Characterization and Therapeutic Potency. (1st July 2016)

82. O2‐13‐03: Efficacy of ACI‐35, A Liposomal Anti‐Phospho Tau Vaccine in Two Different Mouse Models of Alzheimer's Disease. (1st July 2016)

83. O2‐13‐04: Early Clinical Results and Preclinical Validation of the O‐Glcnacase (OGA) Inhibitor Mk‐8719 as a Novel Therapeutic for the Treatment of Tauopathies. (1st July 2016)